2024 AIM Annual Survey
AIM’s 2024 annual survey assessed and characterized IP policy, infrastructure, program activities, priorities, and the impact of funding changes on IPs.
AIM’s 2024 annual survey assessed and characterized IP policy, infrastructure, program activities, priorities, and the impact of funding changes on IPs.
AIM hosted a coalition-focused webinar, Building and Sustaining an Immunization Coalition: The Secrets to Success on August 13.
At this webinar, attendees heard from three speakers about engaging adolescents with vaccine-related content on social media platforms.
The fourth session of the Birthing Hospitals and VFC: A Learning Collaborative to Protect Infants from RSV, was held on August 11.
Announcing the 2025 Immunization Champions award winners! Please read through to learn more about the 2025 Champions from various jurisdictions.
During this webinar, attendees learned about autism spectrum disorder and how the vaccine-autism claim emerged, gained traction, and why it remains persistent.
On June 17, AIM hosted a special webinar, Responding to Measles Outbreaks in High Priority Populations Part II.
Read AIM’s 2025 Exhibitor Prospectus for more information on the AIM Alliance program and exhibiting opportunities and benefits.
Vaccine-related legislated movement has slowed significantly as most state sessions come to an end. This is the last bi-weekly Legislative Round-up of 2025.
Half of the state’s legislative sessions have concluded for the year, with 25 states still underway.